7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
Tirzepatide (Zepbound) changes body composition on DEXA scans. Learn how much fat vs. Lean mass is lost, when to schedule scans, and how to protect muscle during treatment.
Clinical evidence on how Zepbound (tirzepatide) affects estimated glomerular filtration rate (eGFR), including trial data, magnitude of change, monitoring timelines, and what the numbers mean for kidney health.
Zepbound (tirzepatide) significantly lowers fasting insulin levels through dual GIP/GLP-1 receptor activity. Learn the magnitude, timeline, mechanism, and monitoring strategy backed by SURMOUNT trial data.
Tirzepatide (Zepbound) lowers fasting triglycerides by 20 to 30% in clinical trials. Learn the mechanism, timeline, expected magnitude, and monitoring schedule.
Zepbound (tirzepatide) lowers HbA1c by 0.3 to 2.4 percentage points depending on baseline glucose status. Review the SURMOUNT trial data, mechanism, monitoring schedule, and what to expect.
Tirzepatide (Zepbound) significantly reduces visceral adipose tissue. Learn the clinical data on VAT loss magnitude, timeline, mechanisms, and monitoring from SURMOUNT trials.
Tirzepatide (Zepbound) changes kidney function markers, liver enzymes, glucose, and electrolytes on a CMP. Here is what RCT data, FDA labeling, and post-market reports show about direction, magnitude, timing, and monitoring intervals.